COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 62: Articles 611-620  | Next

Impact of extending lockdown on COVID-19 dynamic during 2021 in London: a mathematical modelling study
Ramdani, N.
10.1101/2025.04.02.25325123 — Posted: 2025-04-04
Assessment of Nirmatrelvir-Ritonavir Effects on Acute and Post-Acute COVID-19 Illness in US Adolescents: Target Trial Emulation
Shen, Y., Zhang, B., Jhaveri, R., Tong, J., ZHOU, T., Chen, J., Zhang, D., Wu, Q., Zang, C., Wang, F., Kaushal, R., Newland, J. G., Taylor, E., Herring, S. J., Bisyuk, Y., Liebovitz, D. M., Kim, S., Fort, D., Williams, D. A., Horne, B. D., Cummins, M., Liu, M., Chrischilles, E. A., Cowell, L. G., Mosa, A. S. M., Patel, P., Forrest, C. B., Chen, Y.
10.1101/2025.04.02.25324861 — Posted: 2025-04-04
Sickness Absence Rates in NHS England Staff during the COVID-19 Pandemic: insights from multivariate regression and time series modelling
McTaggart, E., Megiddo, I., Bowers, J., Kleczkowski, A.
10.1101/2025.04.02.25325152 — Posted: 2025-04-04
Ethnic inequalities in loneliness in Britain during the COVID-19 pandemic: Evidence for Equality National Survey (EVENS)
Ma, Z.-H., Irizar, P., Kaushal, A.
10.1101/2025.04.02.25325107 — Posted: 2025-04-04
Optimized pipeline for generating highly potent neutralizing Affitins: application to SARS-CoV-2 spike protein
Maurice, T., Laporte, M., Barquilla, N., Fortun, A., Echasserieau, K., Guivel-Benhassine, F., Barbosa, A., Cossard, P., Planchais, C., Anna, F., Charneau, P., Mouquet, H., Roque, C., Schwartz, O., Mouratou, B., Davodeau, F., Bernardeau, K., Monel, B., Pecorari, F.
10.1101/2025.04.03.646589 — Posted: 2025-04-04
Crosstalk Among Disrupted Blood-Brain Barrier, Neuroinflammation, and Coagulopathy in AC70 hACE2 Tg Mice with Prolonged Neurological Manifestations Induced by the Omicron BA.1 Variant of SARS-CoV-2
Drelich, A. K., Saenkham-Huntsinger, P., Wang, Y.-H. E., Xie, X., Judy, B. M., Ksiazek, T. G., Peng, B.-H., Tseng, C.-T. K.
10.1101/2025.04.03.646981 — Posted: 2025-04-04
Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturer
Peters, M. Q., Young, A. L., Stolarczuk, J. E., Glad, M., Layton, E., Logue, J. K., Minkah, N. K., Chu, H. Y., Englund, J. A., Sather, N., Seshadri, C., Kachikis, A., Harrington, W. E.
10.1101/2025.04.02.646864 — Posted: 2025-04-04
Omics-Based Computational Approaches for Biomarker Identification, Prediction, and Treatment of Long COVID
Pinero, S. L., Li, X., Zhang, J., Winter, M., Lee, S. H., Nguyen, T., Liu, L., Li, J., Le, T. D.
10.1101/2025.04.01.25324942 — Posted: 2025-04-03
Effect of the S2' site cleavage on SARS-CoV-2 spike
Shi, W., Jonaid, G., Kibria, M. G., Allen, J., Peng, H., Rits-Volloch, S., Zhu, H., Wang, S., Walsh, R. M., Lu, J., Chen, B.
10.1101/2025.04.02.646838 — Posted: 2025-04-03
Defining effective strategies to integrate multi-sample single-nucleus ATAC-seq datasets via a multimodal-guided approach
Weinand, K., Langan, E. M., Curtis, M., Raychaudhuri, S.
10.1101/2025.04.02.646871 — Posted: 2025-04-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).